[{"NetIncomeLoss_1_Q1_USD":-222719000.0,"InterestPaidNet_1_Q1_USD":7530000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-357000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":738000000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":1460000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":276000000.0,"IncomeTaxesPaid_1_Q1_USD":3017000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q1_pure":0.009,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":141609000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":564859000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-7372000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-4500000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":0.0,"AssetsCurrent_0_Q1_USD":2246784000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-6362000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":16696000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":0.0,"TreasuryStockShares_0_Q1_shares":408989.0,"TreasuryStockValue_0_Q1_USD":44457000.0,"InterestExpenseDebtExcludingAmortization_1_Q1_USD":3047000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-9000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":157557000.0,"CommonStockSharesIssued_0_Q1_shares":74470583.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":2250000.0,"Assets_0_Q1_USD":2608366000.0,"ShareBasedCompensation_1_Q1_USD":53060000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":1.403,"AccruedLiabilitiesCurrent_0_Q1_USD":148611000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":-400000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":7134000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":427000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-1349000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":11971000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-6593000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":3017000.0,"IncreaseDecreaseInDeferredRevenue_1_Q1_USD":549584000.0,"CommonStockValue_0_Q1_USD":745000.0,"Revenues_1_Q1_USD":447229000.0,"InvestmentIncomeNet_1_Q1_USD":362000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":53325000.0,"BusinessAcquisitionsProFormaRevenue_1_Q1_USD":447229000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":576987000.0,"CostsAndExpenses_1_Q1_USD":655861000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-230100000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":100000.0,"OtherAssetsNoncurrent_0_Q1_USD":31929000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1995482000.0,"Liabilities_0_Q1_USD":1569239000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-9000.0,"MarketableSecuritiesCurrent_0_Q1_USD":2250000.0,"ConvertibleLongTermNotesPayable_0_Q1_USD":322390000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":63190000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":73035000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":427000.0,"UnamortizedDebtIssuanceExpense_0_Q1_USD":2610000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":592671000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":564859000.0,"DebtInstrumentFaceAmount_0_Q1_USD":325000000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":663085000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_1_Q1_USD":222719000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":13781000.0,"LiabilitiesCurrent_0_Q1_USD":1208555000.0,"DeferredRevenueCurrent_0_Q1_USD":822809000.0,"AccountsPayableCurrent_0_Q1_USD":113605000.0,"InterestExpense_1_Q1_USD":4839000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":2029070000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":114731000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":1.247,"ProceedsFromStockOptionsExercised_1_Q1_USD":26750000.0,"InterestExpenseDebt_1_Q1_USD":3403000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":5270000.0,"FinanceLeaseRightOfUseAssetAmortization_1_Q1_USD":951000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_1_Q1_USD":7292000.0,"ShortTermLeaseCost_1_Q1_USD":127600000.0,"AdditionalPaidInCapital_0_Q1_USD":3180114000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q1_pure":0.005,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":5270000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"IncomeLossAttributableToParent_1_Q1_USD":-219702000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":9076000.0,"ReceivablesNetCurrent_0_Q1_USD":56898000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":81600000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":192044000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-7372000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":53060000.0,"Goodwill_0_Q1_USD":130879000.0,"LongTermDebtPercentageBearingFixedInterestRate_0_Q1_pure":0.0375,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-220205000.0,"CommonStockSharesAuthorized_0_Q1_shares":600000000.0,"OperatingIncomeLoss_1_Q1_USD":-208632000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q1_USD":81500000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":12404000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":2608366000.0,"PreferredStockSharesAuthorized_0_Q1_shares":2000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":53060000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":320000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":32128000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-3.05,"OtherLiabilitiesNoncurrent_0_Q1_USD":21598000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"FinanceLeaseLiabilityCurrent_0_Q1_USD":121144000.0,"StockholdersEquity_0_Q1_USD":1039127000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":2250000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q1_USD":427000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-2096918000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":1380332000.0,"CommonStockSharesOutstanding_0_Q1_shares":74061594.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":427000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":2167000.0,"AmortizationOfFinancingCosts_1_Q1_USD":356000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":427000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-7381000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":0.0,"OtherLiabilitiesCurrent_0_Q1_USD":2386000.0,"UnbilledReceivablesCurrent_0_Q1_USD":45295000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]